Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

rts to develop "an antibody for covid-19. `We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and others

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

to develop "an antibody for covid-19. ... 'We have been thinking about and preparing for this for a long time, and it's almost a bit surreal,' said Amy Jenkins, manager of DARPA's antibody program, which is known as the Pandemic Prevention Platform, or P3." According to the Post, "In that program and other